XBiotech Commences Tender Offer to Purchase up to $420,000,000 of its Shares
The Offer is made upon the terms and subject to the conditions described in the offer to purchase and in the related letter of transmittal.
- The Offer is made upon the terms and subject to the conditions described in the offer to purchase and in the related letter of transmittal.
- The Offer is scheduled to expire at 5:00 p.m., New York City time, on February 12, 2020, unless the Offer is extended.
- However, the Offer is subject to a number of other terms and conditions, which are described in detail in the offer to purchase.
- XBiotech currently is advancing a pipeline of therapies by harnessing naturally occurring antibodies from patients with immunity to certain diseases.